R&D Systems Human JAM-C Fc Chimera Recombinant Protein
Manufacturer: R&D Systems 1189J3050
DescriptionMeasured by its ability to inhibit the adhesion of J45.01 human acute lymphoblastic leukemia T lymphocytes on immobilized JAM-2 (VE-JAM)/Fc Chimera. When 0.2 µg/mL (100 µL/well) of rhJAM-B/Fc Chimera is immobilized on goat anti-human IgG Fc Chimera antibody coated wells, the ED 50 for this effect is 0.1-0.5 µg/mL in the presence of 1 x 10 5 cells/well.
|Lyophilized from a 0.2μm filtered solution in Tris-Citrate and NaCl.|
|50 kDa (monomer)|
|90%, by SDS-PAGE under reducing conditions and visualized by silver stain.|
|JAM-C Fc Chimera|
|Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution.|
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.
Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.Ok